"Hemolysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Descriptor ID |
D006461
|
| MeSH Number(s) |
C23.550.403 G12.122.545
|
| Concept/Terms |
Extravascular Hemolysis- Extravascular Hemolysis
- Extravascular Hemolyses
- Hemolyses, Extravascular
- Hemolysis, Extravascular
Intravascular Hemolysis- Intravascular Hemolysis
- Hemolyses, Intravascular
- Hemolysis, Intravascular
- Intravascular Hemolyses
|
Below are MeSH descriptors whose meaning is more general than "Hemolysis".
Below are MeSH descriptors whose meaning is more specific than "Hemolysis".
This graph shows the total number of publications written about "Hemolysis" by people in this website by year, and whether "Hemolysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 2 | 1 | 3 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 12 | 20 | 32 |
| 2018 | 10 | 20 | 30 |
| 2019 | 8 | 11 | 19 |
| 2020 | 3 | 2 | 5 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hemolysis" by people in Profiles.
-
COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria. Blood. 2021 07 01; 137(26):3670-3673.
-
Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach. Biomolecules. 2021 04 27; 11(5).
-
COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients. Nucleosides Nucleotides Nucleic Acids. 2021; 40(5):505-517.
-
Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review. Mol Biol Rep. 2021 Mar; 48(3):2973-2978.
-
Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura. J Clin Apher. 2021 Jun; 36(3):499-504.
-
Estimation of the uncertainty of values assigned to calibration materials prepared in-house: An example for hydroxychloroquine calibrators in blood-hemolysate-based matrix. Clin Biochem. 2021 Mar; 89:70-76.
-
COVID-19-associated oxidative damage to red blood cells. Br J Haematol. 2021 05; 193(3):481.
-
Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine? J Pediatr Hematol Oncol. 2021 01; 43(1):35-36.
-
Are oral manifestations related to SARS-CoV-2 mediated hemolysis and anemia? Med Hypotheses. 2021 01; 146:110413.
-
Evaluating blood product quality post expiry to mitigate blood shortages during the COVID-19 pandemic in Canada. Transfusion. 2020 12; 60(12):3072-3074.